Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Cash from Financing Activities (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Cash from Financing Activities for 6 consecutive years, with $2.5 million as the latest value for Q2 2025.

  • Quarterly Cash from Financing Activities fell 93.65% to $2.5 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $70.5 million through Jun 2025, up 3.61% year-over-year, with the annual reading at $70.5 million for FY2025, 3.61% up from the prior year.
  • Cash from Financing Activities hit $2.5 million in Q2 2025 for Benitec Biopharma, down from $28.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $40.1 million in Q2 2024 to a low of $3000.0 in Q1 2021.
  • Historically, Cash from Financing Activities has averaged $16.7 million across 5 years, with a median of $16.9 million in 2022.
  • Biggest five-year swings in Cash from Financing Activities: soared 45720.51% in 2024 and later tumbled 93.65% in 2025.
  • Year by year, Cash from Financing Activities stood at $12.7 million in 2021, then grew by 26.42% to $16.0 million in 2022, then plummeted by 99.76% to $39000.0 in 2023, then skyrocketed by 45720.51% to $17.9 million in 2024, then crashed by 85.76% to $2.5 million in 2025.
  • Business Quant data shows Cash from Financing Activities for BNTC at $2.5 million in Q2 2025, $28.4 million in Q1 2025, and $17.9 million in Q4 2024.